Search research articles
Contact Us
Filters
Showing results (11-20 of 145) with videos related to
Page
of 15
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 29, 2025
Treatment discontinuation in MOGAD: A reassuring step forward
Yael Hacohen, Romain Marignier
The Israel Medical Association Journal : IMAJ
|
October 25, 2006
Should folic acid fortification be mandatory in Israel?
Yael Hacohen, Tally Lerman-Sagie
Handbook of Clinical Neurology
|
September 25, 2024
Pediatric inflammatory leukoencephalopathies
Omar Abdel-Mannan, Yael Hacohen
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 23, 2021
Aquaporin-4 antibody neuromyelitis optica spectrum disorder: A paraneoplastic disease?
Omar Abdel-Mannan, Yael Hacohen
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 10, 2018
Clinical commentary on 'Late-onset neutropenia and neurological relapse during long-term rituximab therapy in MOG antibody spectrum disorder'
Yael Hacohen, Wallace J Brownlee
Neurology
|
May 13, 2021
Intrathecal Production of MOG-IgG: Highlighting the Need for CSF Testing in Clinical Practice
Yael Hacohen, Wesley Kerr, Patrick Waters
Brain : a Journal of Neurology
|
October 21, 2017
Abnormal white matter development in children with multiple sclerosis and monophasic acquired demyelination
Yael Hacohen, Olga Ciccarelli, Cheryl Hemingway
Pediatric Clinics of North America
|
May 30, 2015
Autoimmune encephalopathies
Ming Lim, Yael Hacohen, Angela Vincent
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 8, 2020
What does first-line therapy mean for paediatric multiple sclerosis in the current era?
Yael Hacohen, Brenda Banwell, Olga Ciccarelli
JAMA Network Open
|
September 28, 2022
Considering the Future of Pediatric Multiple Sclerosis Trials After the CONNECT Open-Label Randomized Trial
Omar Abdel-Mannan, Olga Ciccarelli, Yael Hacohen
Page
of 15
Search research articles
Search
Showing results (11-20 of 145) with videos related to
Sort By:
Page
of 15
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 29, 2025
Treatment discontinuation in MOGAD: A reassuring step forward
Yael Hacohen, Romain Marignier
The Israel Medical Association Journal : IMAJ
|
October 25, 2006
Should folic acid fortification be mandatory in Israel?
Yael Hacohen, Tally Lerman-Sagie
Handbook of Clinical Neurology
|
September 25, 2024
Pediatric inflammatory leukoencephalopathies
Omar Abdel-Mannan, Yael Hacohen
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 23, 2021
Aquaporin-4 antibody neuromyelitis optica spectrum disorder: A paraneoplastic disease?
Omar Abdel-Mannan, Yael Hacohen
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 10, 2018
Clinical commentary on 'Late-onset neutropenia and neurological relapse during long-term rituximab therapy in MOG antibody spectrum disorder'
Yael Hacohen, Wallace J Brownlee
Neurology
|
May 13, 2021
Intrathecal Production of MOG-IgG: Highlighting the Need for CSF Testing in Clinical Practice
Yael Hacohen, Wesley Kerr, Patrick Waters
Brain : a Journal of Neurology
|
October 21, 2017
Abnormal white matter development in children with multiple sclerosis and monophasic acquired demyelination
Yael Hacohen, Olga Ciccarelli, Cheryl Hemingway
Pediatric Clinics of North America
|
May 30, 2015
Autoimmune encephalopathies
Ming Lim, Yael Hacohen, Angela Vincent
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 8, 2020
What does first-line therapy mean for paediatric multiple sclerosis in the current era?
Yael Hacohen, Brenda Banwell, Olga Ciccarelli
JAMA Network Open
|
September 28, 2022
Considering the Future of Pediatric Multiple Sclerosis Trials After the CONNECT Open-Label Randomized Trial
Omar Abdel-Mannan, Olga Ciccarelli, Yael Hacohen
Page
of 15